Published November 28, 2017

In a clinical study published in 2014 that included more than 90 sites throughout the U.S. and Canada, Cologuard’s stool DNA technology was evaluated in 10,000 participants. That study showed that Cologuard was able to find early colorectal cancers 94% of the time – every bit as good as colonoscopy without any of the aggravation.

Read More

Published November 25, 2017

Researchers discovered that one form of molecule called PKC-delta actually helps reduce macrophage population, suppressing inflammation. As they continued to investigate, they found that high lipid levels are responsible for triggering the production of PKC-delta to fight inflammation.

Read More

Published November 23, 2017

Researchers found that rates of atherosclerosis were higher in people who didn’t eat breakfast or didn’t eat a hearty breakfast compared to those who ate a substantial breakfast. Those two groups were also more likely to have cardiometabolic risk markers. In particular, those who didn’t eat breakfast at all had the largest waists circumferences, largest body mass indexes, and highest blood pressure, blood lipids, and fasting glucose levels.

Read More